MNT for Liver Flashcards
The liver has over ____ functions
500
Manufactures blood proteins
Rough ER
Produce bile salts and detoxifies blood-borne poisons
Smooth ER
Detoxify other poisons, including alcohol
Peroxisomes
Supplies energy
Mitochondria
Packages
Golgi apparatus
Stores sugar and regulates blood glucose levels
Glycosomes
Produce ____ - _____ mL bile each day
500-1000
Regeneration capacity is done through:
Liver stem cells
Liver manufactures
Protein
Glycogen
Bile
Cholesterol
Liver stores
Iron
Fat-soluble vitamins
Glycogen
Liver wastes
Ammonia
Drugs and alcohol
Bilirubin
Bacteria
Diseases of the liver
Hepatitis - acute viral, fulminant, chronic
Alcoholic liver disease, alcoholic hepatitis, and cirrhosis
NASH
Cholestatic liver disease (primary biliary cirrhosis, cholangitis)
Inherited disorders
Other liver diseases
Features similar to acute hepatitis but with more severe liver damage and serious clinical state
Acute liver failure
Present in acute liver failure but not in acute hepatitis
Encephalopathy
Poor coagulation
Hepatic atrophy
Brain edema
High risk of death without transplant
Hallmark of infection
HBsAg
Acute infection (serological marker)
Anti-HBc IgM
Resolved infection (serological marker)
Anti-HBc total
High viral load and high infectivity
HBeAg
Antibody to HBeAg, indicates decreasing HBV DNA
Anti-HBe
Recovery from acute infection
Anti-HBs
Widespread inflammation of the liver caused by hepatitis viruses A, B, C, D, and E
Acute hepatitis
Hepatitis A:
Oral and fecal route
Hepatitis B and C:
Body fluids
Hepatitis D
Occurs only in parts with B
Hepatitis E:
Oral fecal route, most seen in Asia, Africa, and Mexico
4 phases of symptoms
Prodromal
Pre-icteric
Icteric
Convalescent
Malaise, fatigue, low-grade fever, nausea vomiting, aversion to food, mild itching, joint/muscle pain
Prodromal
Icteric
Yellow eyes, dark urine, light stool
Gradual recovery
Convalescent
Risk factors for chronic hepatitis
Injection drug use
Chronic hemodialysis
Blood transfusion
Blood receipt
Clotting factor receipt
Unvaccinated health care worker
Asian ancestry
Birth to mother with chronic HBV or HCV
Possible risk factors
Piercings or tattoos
Multiple sexual partners
Health care worker
Exposure to positive person
6-month course of hepatitis or evidences of liver disease with confirmatory biopsy
Chronic hepatitis
Caused by alcohol excess and abuse
Alcohol liver disease
Most common liver disease
Alcoholic liver disease
Stages of alcoholic liver disease
Hepatic steatosis (fatty liver)
Alcoholic Hepatitis
Alcoholic Cirrhosis
Alcoholic liver disease: metabolic changes
Steatorrhea
Wernicke-Korsakoff syndrome
Pellagrous psychosis
Peripheral neuropathy
Folate deficiency
Possible characteristics of end-stage alcoholic liver disease
Malnutrition
Portal hypertension with varices
Ascites
Hyponatremia
Hepatic encephalopathy
Glucose alteration
Fat malabsorption
Osteopenia
Thrombocytopenia with anemia
Histologically resembles alcoholic hepatitis
Most common cause of chronic hepatic injury other than viruses or alcohol
Most common cause of cryptogenic cirrhosis
Common in middle-aged women with obesity or diabetes
NASH
True or False: ALT is higher than AST for NASH
True
True or False: ALT is higher than AST for NASH
True
T or F: People with NASH generally have normal lipid profiles
False
Give some clinical manifestations of cirrhosis
Ascites
Spider angioma
Jaundice
Testicular atrophy
Caput medusae
Gynecomastia
Alopecia
Icteric sclera
Asterixis
Palmar erythema
Altered hair distribution
Edema
Bruising
Muscle wasting
These are the enzymes released into circulation following injury or death of cells in the liver, heart, lungs, etc.
ALT and AST
True or False. High AST and ALT are indicative of liver disease in the presence of jaundice or other symptoms. Levels are lower for acute hepatic injury than in chronic liver disease
Statement 1 - True
Statement 2 - False (higher)
Transaminase levels will relate more to the ____ rather than the _____.
Cause; prognosis
Usually normal in chronic and acute liver disease
ALP
ALP
Alkaline phosphatase
High levels are indicative of obstruction of biliary drainage
ALP
Viral hepatitis: bilirubin is
> 257 mcmol
Alcoholic hepatitis, bilirubin is
> 428 mcmoles per L - likelihood of death
Protein-bound, related to the breakdown of RBCs
Unconjugated/indirect bilirubin
Non-protein bound with increased in blockage of the liver
Conjugated/direct bilirubin
Non-protein bound with increased in blockage of the liver
Conjugated/direct
Conditions related to increased direct bilirubin
Viral hepatitis
Cirrhosis
Infectious mononucleosis
Reaction to drugs (chlorpromazine - a sedative used for psychotic orders)
Obstruction of the CBD (gallstones, neoplasms)
Conditions related to increased indirect bilirubin
Blood transfusion
Pernicious anemia
Sickle cell anemia
Transfusion reactions
Low ceruloplasmin indicates
High unbound copper
Hepatolenticular degeneration caused by abnormal copper accumulation in the body
Wilson’s disease
Most cost-effective screening test for metabolic or drug-induced liver injury
ALT
Predictors of prognosis
PTT
Albumin - low - high risk of death
Causes of Malnutrition in Liver disease
Restricted diets
Anorexia
Altered metabolism
Maldigestion of malabsorption
Early satiety or dysguesia
Nausea and vomiting
Medical Management of liver disease
Diuretic therapy
Management of portal hypertensive bleeding
Medication of encephalopathy
Monitoring of blood glucose
MNT for liver disease
Increased energy intake - small, frequent feedings
Sodium restriction for ascites
Fluid restriction for hyponatremia
Carbohydrate-controlled for hyperglycemia
V &M Supplements
Oral liquid supplements or TF
Vitamin/Mineral Deficits in severe liver disease
ADEK
B1 B3 B6 B9 B12
Zn Mg Fe K P
Refers to any type pf cerebral dysfunction that is due to liver insufficiency and/or portosystemic shnting
Hepatic encephalopathy
Major causes of encephalopathy
GI bleeding
Fluid and electrolyte abnormalities
Uremia
Use of sedatives
Hypo/hyperglycemia
Alcohol withdrawal
Constipation
Acidosis
Non-absorbable disaccharide that acidifies colonic contents and acts as laxative
Lactulose
Non-absorbable antibiotic that decreases colonic ammonia production
Neomycin
True or false: Ascites increases REE by 10%
True
Energy, protein, and fat recommendations for MNT end-stage liver disease
Energy - 25-30 kcal/kg BW
Protein - 1-1.5 g/kg
Fat - 25-40% of kcal
Recommendations for sodium
1500-2000 mg/day
Recommendations for fluid
1000-1500 mL/day
In liver diseases, aromatic AA are usually decreased and BCAAs are increased
False
Aromatic AA
Free tryptophan, tyrosine, phenylalanine
If steatorrhea is present, replace
LCT with MCT
If steatorrhea is present, replace
LCT with MCT